No sides. Just data.

We compare what the media report with what the data say

World · International

Boom in weight-loss drugs could lead to fall in beer sales, Heineken warns UK pubs

Outlet: The Guardian · Mark Sweney · Published 23/10/2026 09:08 UTC

Only The Guardian reports this: no contrast yet

None of the other outlets we follow has reported this story, so there are no versions to compare. If others publish it or data appear that test it, it will move to the comparison.

World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol • Business live – latest updates Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider. The world’s second-largest brewer sent a presentation to British hospitality customers earlier this month that said the use of GLP-1 medication – such as Ozempic and Wegovy – could reduce the desire to drink alcohol . This in turn could result in “fullness and fewer serves” of pints in pubs and bars, it added. Continue reading.

Read on the original outlet ↗

Changes detected 2

The outlet changed this story after we captured it. We keep the previous version, its fingerprint and the date we saw the change.

  1. Excerpt · detected on 23/10/2026 10:39 UTC

    World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol • Business live – latest updates Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider. The world’s second largest second-largest brewer sent a presentation to British hospitality customers earlier this month warning that said the use of GLP-1 use medication – led by such as Ozempic and Wegovy – can could reduce the desire to drink alcohol , which . This in turn could lead to result in “fullness and fewer serves” of pints in pubs and bars. bars, it added. Continue reading... reading.

    See versions and fingerprints

    Before: «World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider. The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – can reduce the desire to drink alcohol , which could lead to “fullness and fewer serves” of pints in pubs and bars. Continue reading...» 5e1ba5f551ac

    After: «World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol • Business live – latest updates Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider. The world’s second-largest brewer sent a presentation to British hospitality customers earlier this month that said the use of GLP-1 medication – such as Ozempic and Wegovy – could reduce the desire to drink alcohol . This in turn could result in “fullness and fewer serves” of pints in pubs and bars, it added. Continue reading.» d06f918af4e7

  2. Headline · detected on 23/10/2026 10:39 UTC

    Boom in weight-loss drugs could lead to drop fall in beer sales, Heineken warns British UK pubs

    See versions and fingerprints

    Before: «Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs» ff49d2835280

    After: «Boom in weight-loss drugs could lead to fall in beer sales, Heineken warns UK pubs» 1a2d4c41121e

Capture record

Source
https://www.theguardian.com/business/2026/oct/23/weight-loss-drugs-beer-sales-heineken-british-pubs-wegovy
Published
23/10/2026 09:08 UTC
Captured
23/10/2026 09:39 UTC
Text fingerprint
12fa3dc267ad56fd · 368 words
Changes detected
2
Archived copy
Wayback Machine ↗

The fingerprint (sha256) and the capture date prove what the story said when we analysed it, even if it changes later.

More contrasts in world